Home›Stocks›BRVE

BRVE — structural market context

Braveheart Bio, Inc.

Structural market context from public regulatory and market data, shown with its as-of dates. Descriptive only: nothing on this page is a recommendation, a prediction, or advice to buy or sell any security.

What changed

What changed is temporarily unavailable.

BRVE short interest & days to cover

SHARES SHORT
4.1M
% OF FLOAT
—
DAYS TO COVER
5.1
CHANGE VS PRIOR
+67.8%

FINRA consolidated short interest, reported twice a month and published ~2 weeks after each settlement date. % of float uses reported free float. · as of 2026-09-30 (17d ago)

BRVE fails-to-deliver (FTD)

Settlement dateFailed sharesPrice
2026-09-30 · 17d3K$22.34
2026-09-29 · 18d6$21.07
2026-09-25 · 22d13K$23.37

SEC fails-to-deliver files, published twice a month with ~6 weeks of delay.

BRVE analyst ratings

FirmActionRatingPublished
Cantor FitzgeraldinitialiseOverweight2026-08-31
Cantor Fitzgeraldprice_target—2026-08-31
Cowen & Co.initialiseBuy2026-08-31
Jefferiesprice_target—2026-08-31
JefferiesinitialiseBuy2026-08-31

Rating actions as published by the firms, from public feeds. They are not graded here.

Frequently asked questions

What do analysts say about BRVE?
The most recent action: Cantor Fitzgerald initialise to Overweight on 2026-08-31. Rating actions are shown as published by the firms; they are not graded here.
Is this page telling me to buy or sell BRVE?
No. Everything on this page is descriptive, structural market context from public data, shown with its as-of dates. TradeAI News does not issue directional recommendations, price predictions, or buy/sell advice — for any ticker.
All covered stocksShort Interest & FTD trackerInsider Buying trackerThe platform

More tickers starting with B

BABA · Alibaba Group Holding LimitedBE · Bloom Energy CorporationBTI · British American Tobacco p.l.cBBNX · Beta Bionics, Inc. Common StocBCDA · BioCardia, Inc.BELFB · Bel Fuse Inc.All B →

This is the teaser.

Latest rows shown. Full history, market-wide screens, cluster detection and the context journal live in the dashboard.

Start free →View plans →

Not financial advice. Trading involves risk. Descriptive structural context, never a recommendation.